Literature DB >> 27003595

Can pelvic floor muscle training improve quality of life in men with mild to moderate post‑stroke and lower urinary tract symptoms?

Sigrid Tibaek1, Gunvor Gard2, Christian Dehlendorff3, Helle K Iversen4, Fin Biering-Soerensen5, Rigmor Jensen4.   

Abstract

BACKGROUND: Lower urinary tract symptoms (LUTS) have a significant impact on quality of life (QoL) in post‑stroke patients. AIM: The aim of this study was to evaluate the effect of pelvic floor muscle training (PFMT) on QoL parameters in men with post‑stroke LUTS.
DESIGN: Randomized, controlled and single‑blinded trial.
SETTING: Outpatients, University Hospital. POPULATION: Thirty‑one men, median age 68 (interquartile range 60-74) years, with post‑stroke LUTS were included. Thirty participants completed the study.
METHODS: The participants randomized to the treatment group were treated in a systematic, controlled and intensive PFMT program over 3 months (12 weekly sessions). The participants randomized to the control group did not receive specific LUTS treatment. The effect was measured on the 36-Item Short Form Health Survey (SF-36) and the Nocturia Quality‑of‑Life (N‑QoL) Questionnaire.
RESULTS: The results on SF-36 indicated significant improvement within pre- and post‑test in the domains emotional role (median 77 to 100, P=0.03) and vitality (median 65 to 70, P=0.03) in the treatment group, but not the control group. There were no statistically significant differences between groups at pre‑test, post‑test or 6-month follow‑up. The results on N‑QoL indicated statistically significant differences between pre- and post‑test in the bother/concern domain in both groups and in sleep/energy for the control group, but not the treatment group. There were no statistically significant differences between groups.
CONCLUSIONS: PFMT may improve the emotional health and vitality domains of QoL in men with mild to moderate post‑stroke and LUTS; however the improvements in the treatment group were not significantly better than for the control group. PFMT did not improve nocturia‑related QoL. CLINICAL REHABILITATION IMPACT: This study is the first to evaluate the effect of PFMT on QoL parameters in men with mild to moderate post‑stroke and LUTS. The results indicate some short‑term effect on SF-36 but none on N‑QoL. However, further studies with larger sample sizes and with less restrictive inclusion and exclusion criteria are requested.

Entities:  

Mesh:

Year:  2016        PMID: 27003595     DOI: 10.23736/S1973-9087.16.04119-8

Source DB:  PubMed          Journal:  Eur J Phys Rehabil Med        ISSN: 1973-9087            Impact factor:   2.874


  5 in total

1.  The effect of pelvic floor muscle training on urinary incontinence in patients with stroke: a systematic review and meta-analysis.

Authors:  Fatih Özden; İsmet Tümtürk; Mehmet Özkeskin; Serkan Bakırhan
Journal:  Ir J Med Sci       Date:  2022-07-01       Impact factor: 1.568

2.  Interventions for treating urinary incontinence after stroke in adults.

Authors:  Lois H Thomas; Jacqueline Coupe; Lucy D Cross; Aidan L Tan; Caroline L Watkins
Journal:  Cochrane Database Syst Rev       Date:  2019-02-01

3.  Lower Urinary Tract Symptoms, Erectile Dysfunction, and Quality of Life in Poststroke Men: A Controlled Cross-Sectional Study.

Authors:  Sigrid Tibaek; Gunvor Gard; Christian Dehlendorff; Helle K Iversen; Fin Biering-Soerensen; Rigmor H Jensen
Journal:  Am J Mens Health       Date:  2017-02-13

4.  Effects of listening to Holy Qur'an recitation and physical training on dialysis efficacy, functional capacity, and psychosocial outcomes in elderly patients undergoing haemodialysis.

Authors:  Bechir Frih; Wajdi Mkacher; Abir Bouzguenda; Hamdi Jaafar; Salem Ali ALkandari; Zohra Ben Salah; Bart Sas; Mohamed Hammami; Ameur Frih
Journal:  Libyan J Med       Date:  2017-12       Impact factor: 1.657

5.  Effects of nonsurgical, minimally or noninvasive therapies for urinary incontinence due to neurogenic bladder: a systematic review and meta-analysis.

Authors:  Mohammed Usman Ali; Kenneth Nai-Kuen Fong; Priya Kannan; Umar Muhammad Bello; Georg Kranz
Journal:  Ther Adv Chronic Dis       Date:  2022-03-18       Impact factor: 5.091

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.